$AKTX - Akari Therapeutics Announces Positive Interim Data from Phase III Paroxysmal Nocturnal Hemoglobinuria (PNH) Study: https://finance.yahoo.com/news/akari-therapeutics-announces-positive-interim-143009624.html
$AZRX - AzurRx BioPharma To Present Interim Phase 2 Clinical Study Data for MS1819-SD, in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency, at Biotech Showcase 2020 Conference (January 13) in San Francisco: https://finance.yahoo.com/news/azurrx-biopharma-present-interim-phase-002235966.html
$CPAH - CounterPath Chosen by Honeywell to Create Unified Communications (UC) Solution for Mobile Devices and Handheld Scanners: https://finance.yahoo.com/news/counterpath-chosen-honeywell-create-unified-210500359.html
$SRNE - Sorrento surges on a near $1 billion takeout offer: https://finance.yahoo.com/news/sorrento-surges-near-1-billion-152934800.html
$TRIL - Continuation